Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

The market for sphygmomanometers has experienced significant growth recently, driven by increasing health awareness and advances in medical technology. This sector continues to evolve rapidly, influenced by rising rates of hypertension and a shift toward more modern, connected healthcare devices. Below, we explore the current market size, key drivers, segmentation, emerging trends, leading players, and regional outlook shaping the future of the sphygmomanometer industry.

Sphygmomanometer Market Size and Expected Growth Trajectory

The sphygmomanometer market has expanded steadily in recent years and is projected to grow from $3.2 billion in 2025 to $3.53 billion in 2026, at a compound annual growth rate (CAGR) of 10.3%. This growth during the past period is largely due to the increasing prevalence of hypertension, the historical reliance on mercury-based devices, more frequent clinical screenings, the expansion of primary healthcare centers, and ongoing use of manual and aneroid models.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10396&type=smp

Looking ahead, the market is expected to grow even faster, reaching $5.31 billion by 2030 with a CAGR of 10.7%. This forecasted increase is driven by rising demand for remote patient monitoring, wider adoption of connected healthcare technology, growth in telemedicine services, a stronger focus on preventive cardiovascular care, and the gradual replacement of mercury-based sphygmomanometers. Key trends include the growing popularity of digital blood pressure monitors, the surge in home-based monitoring, integration of data connectivity, portable and wearable device options, and an emphasis on accuracy and user-friendliness.

Factors Behind Rising Demand in the Sphygmomanometer Market

A major contributor to market growth is the escalating burden of chronic non-communicable diseases (NCDs), especially hypertension and cardiovascular disorders. These long-term conditions progress slowly and require continuous monitoring and management. Hypertension, in particular, is a significant global health issue and a leading risk factor for cardiovascular complications, making regular blood pressure monitoring critical for early diagnosis and effective treatment.

Access The Complete Sphygmomanometer Market Report:

https://www.thebusinessresearchcompany.com/report/sphygmomanometer-global-market-report

Lifestyle factors such as an aging global population, unhealthy diets, reduced physical activity, and increasing obesity rates are fueling the rise in blood pressure irregularities worldwide. Sphygmomanometers are essential tools for timely diagnosis, ongoing monitoring, and enhanced management of cardiovascular risks in both clinical environments and home settings. For example, the World Health Organization (WHO) reported that in 2024, approximately 1.4 billion adults aged 30 to 79 were living with hypertension, constituting 33 percent of this demographic. Notably, two-thirds of these individuals reside in low- and middle-income countries, with about 600 million undiagnosed and roughly 630 million receiving treatment. This substantial global health challenge is a key factor driving sphygmomanometer market expansion.

How the Growth of Ambulatory Surgery Centers is Boosting Market Demand

Another important driver for the sphygmomanometer market is the rapid increase in ambulatory surgery centers (ASCs). These specialized medical facilities focus on performing surgical procedures that do not require overnight hospitalization. ASCs depend heavily on sphygmomanometers—commonly known as blood pressure cuffs—to monitor patients’ vital signs before, during, and after surgeries.

In the United States, the number of ambulatory surgery centers is growing steadily. According to CliftonLarsonAllen LLP, as of July 2025, there are over 10,000 ASCs nationwide, with industry revenues projected to rise from approximately $45 billion in 2024 to about $57 billion by 2030. This expansion underscores the increasing demand for sphygmomanometers within these facilities, further stimulating market growth.

Detailed Segmentation of the Sphygmomanometer Market

This market is segmented by product type, configuration, operation mode, and end user. The product categories include Electronic Sphygmomanometers, Aneroid Sphygmomanometers, and Mercury Sphygmomanometers. Configurations are divided into Portable, Desk Mounted, Floor Standing, and Wall Mounted devices. Operational types cover Electric, Manual, Automatic, and Semi-automatic models. End users comprise Hospitals, Ambulatory Surgical Centers and Clinics, Home Healthcare, and other sectors.

Further breakdowns include subtypes such as Upper Arm, Wrist, and Finger Electronic Sphygmomanometers; Manual and Digital Aneroid types; and Standard versus Portable Mercury Sphygmomanometers, allowing for a comprehensive understanding of the market’s structure.

Innovations and Trends Driving the Future of the Sphygmomanometer Market

Leading companies are increasingly focusing on developing advanced automatic blood pressure monitors that incorporate AI-driven diagnostic technologies. These innovations aim to enhance measurement accuracy, facilitate early detection of cardiovascular irregularities, and improve the convenience of home health monitoring.

For example, in November 2024, OMRON Healthcare, a Japan-based company specializing in health equipment, received FDA De Novo authorization for its next-generation home blood pressure monitor featuring IntelliSense AFib. This AI-powered atrial fibrillation detection algorithm analyzes over 300 pulse-wave indices, achieving clinical performance with 95% sensitivity and 98% specificity. This advancement highlights the transformation of automatic oscillometric devices from simple blood pressure tools into comprehensive cardiovascular screening technologies, supporting early diagnosis, ongoing monitoring, and better clinical decision-making.

Key Players Leading the Sphygmomanometer Market Competition

The sphygmomanometer market features several prominent companies driving innovation and competition. Notable players include A&D Company Ltd., American Diagnostic Corporation, Omron Healthcare Inc., Microlife Corporation, Beurer GmbH, CIGA Healthcare Ltd., Rossmax International Ltd., Rudolf Riester GmbH, Welch Allyn Inc., Koninklijke Philips N.V., Paul Hartmann AG, Spengler, Holtex Ltd., Timesco Healthcare Ltd., Bremed Ltd., iHealth Labs Inc., Contec Medical Systems Co. Ltd., SunTech Medical Inc., General Electric Company, Amico Group of Companies, HEINE Optotechnik GmbH & Co. KG, Hill-Rom Services Inc., and Halma plc.

Regional Market Leadership and Growth Forecast

In 2025, North America held the largest share of the global sphygmomanometer market due to its advanced healthcare infrastructure and technology adoption. However, the Asia-Pacific region is anticipated to be the fastest-growing market during the forecast period, driven by increasing healthcare investments and rising awareness about cardiovascular health. The market analysis covers key territories including Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, offering a broad perspective on regional market dynamics.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model